Surgeon Still a Step Behind Medicine: Indicators of Healthcare for Peripheral Artery Disease  by De Rango, P.
INVITED COMMENTARYSurgeon Still a Step Behind Medicine: Indicators of Healthcare for Peripheral
Artery Disease
P. De Rango
Unit of Vascular and Endovascular Surgery, Hospital S. Maria Misericordia, Loc. S. Andrea delle Fratte, 06134 Perugia, ItalyPatients with peripheral arterial disease (PAD) currently
have a range of therapies that might improve outcomes,
including supervised exercise programs, medications,
endovascular procedures, and surgery. An appropriate
clinical approach to PAD could decrease morbidity and
mortality, reduce the risk of amputation, and increase pa-
tients’ functional status and quality of life. Nevertheless, in
clinical practice signiﬁcant judgment by the physician to
adapt the variety of treatments available to the care of each
individual patient with PAD is often required with uncertain
and often unsatisfactory effects on outcomes. Even though
PAD has been extensively researched and is the subject of
many systematic reviews, there is a lack of high qualitative
studies, and of what constitutes optimal management for
patients with the disease. This weakness emerged in the
recent review by Bellmunt et al.,1 which aimed to evaluate
the appropriateness of healthcare provided in PAD by
generating indicators of care based on interventions sup-
ported by strong evidence. To use the best knowledge as a
source of indicators for PAD, literature search was restricted
to systematic reviews, and only recommendations based on
systematic reviews with high methodological quality and
high strength evidence were ﬁnally selected. The results
outlined in Bellmunt’s review identiﬁed six interventions of
what constitutes optimal management for PAD patients and
thereby from which indicators could be derived: four on
pharmacology (antiplatelets, statins, cilostazol, nafti-
drofuryl) and two on lifestyle (exercise and smoking) for
intermittent claudication. Nevertheless, even if based on
the “strongest” evidence, each of these indicators was
derived from one or, exceptionally, two systematic reviews,
most presenting too limited methodology to be applied in
generating indicators.
Systematic reviews are assumed to represent the
highest level of evidence and provide the highest degree
of reliability for management of patient care. If sound and
rigorous methodology is not applied, their strength fails.
High-level scientiﬁc approach barely has been applied in
the several systematic reviews on PAD, especially in those
evaluating surgical techniques in patients with critical
limb ischemia (CLI). In the study by Bellmunt,1 from a
total of almost 2000 systematic reviews on PAD initiallyDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.02.001
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http://dx.doi.org/10.1016/j.ejvs.2014.04.015identiﬁed, only 29 conclusive and high-quality reviews
were retrieved and nine clinical recommendations with
moderate/high strength were ﬁnally selected to generate
six indicators of quality. Of relevance, no quality indicator
could be derived on surgical technique or strategies for
revascularization in PAD because high-quality and strong
evidence was lacking, thus suggesting that the surgeon is
still one step behind medicine in scientiﬁc research and
patient care. Over the past two centuries, surgery has
become radically more reﬁned, effective, and invasive-
ness substantially reduced2 d changes that have been
progressively supported by studies performed by sur-
geons. Nevertheless, despite the increased involvement
in clinical research and the large number of publications
and systematic reviews available today, especially
after the implementation of newer less-invasive tech-
niques, most surgeons still fail to achieve equivalent high-
quality scientiﬁc approach when compared with their
medical counterparts where superior, more reﬁned and
sound methodology is applied. Quality of healthcare is
expected to be uncertain or inferior when provided by
surgeons.
As a result, it is evident that there is a current inability to
judge the performance of patient care with more advanced
peripheral disease, that is patients with CLI, who cannot
beneﬁt from medical therapy alone and require a more
aggressive and invasive treatment to achieve improved
outcomes. Most indicators generated by Bellmunt1 targeted
patients with intermittent claudication, while no consistent
clinical recommendations were found for CLI. Management
of CLI patients remains challenging and prognosis con-
cerning limb salvage, mortality, and quality of life is poor. As
to whether this is because of the particular aggressiveness
of the disease or more likely the lack of high-level meth-
odology research in this ﬁeld, remains an object of debate.
It is evident that there is an extraordinarily large variability
in reporting (deﬁnitions, location, severity of disease; type
of patients, etc.) to reliably assess CLI. Current guidelines
still do not fully address how to best approach this vari-
ability especially in patients with infrapopliteal lesions,
diabetes, and CLI.
In recent years, there has been increased focus on
developing the quality of healthcare for cardiovascular
diseases. According to data there is currently a great need
to improve healthcare performance in patients with PAD.
Despite the large number of published studies, the devel-
opment of evidence-based approach in PAD is limited by
the lack of methodological quality of researches and the
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Implementing rigorous methodology in primary researches
and systematic reviews for PAD may help most surgeons to
achieve more conclusive strategies, increased quality of
healthcare and improved patient outcomes especially for
those with CLI.REFERENCES
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